Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study to Evaluate Efficacy and Safety of Fruquintinib as Second-line Treatment for Patients With Advanced or Metastatic Biliary Tract Cancer

NCT04156958 is registered in ClinicalTrials.gov with Sichuan University as lead sponsor.

NCT NCT04156958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04156958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study to Evaluate Efficacy and Safety of Fruquintinib as Second-line Treatment for Patients With Advanced or Metastatic Biliary Tract Cancer
Lead sponsor
Sichuan University
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2019
Completion date
December 31, 2021
Enrollment
33 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract adenocarcinoma